Dental practices are generally valued based on a combination of collections, profitability, and how predictable that revenue is expected to be after a transition, not just on top-line production alone.
Every valuation approach eventually asks the same underlying question: if a buyer takes over tomorrow, how much of this revenue keeps showing up? A practice with strong collections but a shaky, insurance-dependent revenue base doesn’t get valued the same as a practice with equally strong collections built on relationships that are likely to continue.
Buyers look for predictability, profitability, and patient retention, in that order, because a practice that keeps its patients and its margins after a transition is worth more than one where both are a question mark.
Predictability means revenue that isn’t dependent on any single relationship, including the selling doctor’s. Profitability means the practice keeps a healthy share of what it produces, rather than losing a large percentage to adjustments before it ever reaches the bank. Retention means the patient base actually stays once ownership changes hands, instead of drifting to whichever practice down the street feels familiar. A practice that can show all three, in writing, with real numbers, is a much easier practice to say yes to.
This is also where a lot of owners get caught off guard. A practice can look strong on paper, healthy schedule, steady new patients, solid reviews, and still raise questions during a transition if none of that growth is documented as something repeatable. Buyers aren’t just buying today’s patient base. They’re buying the likelihood that the same patients show up next year, under a different name on the door, and that likelihood is a lot easier to demonstrate with a recurring revenue line than with a schedule that simply “stays full.”
Insurance-dependent revenue drags on value because a meaningful share of what the practice produces never actually gets collected, and what’s left is subject to reimbursement schedules the practice doesn’t control.
The national average insurance write-off sits around 43%, meaning nearly half of what a practice produces on paper doesn’t make it to collections. That’s not a rounding error, it’s a structural cap on profitability that a buyer’s team will find in the numbers whether or not it’s mentioned in a conversation. It also means the practice’s future earnings are tied to decisions made by payers, not by the practice itself, fee schedule changes, network terms, reimbursement delays, none of which the new owner gets any say in. You are producing revenue you do not get to keep, and buyers price that risk in.
Membership revenue changes the picture because it’s patient-paid, recurring, and entirely outside the insurance reimbursement cycle, which makes it a more predictable, more retainable, and generally higher-margin revenue line than insurance-dependent production, provided the plan itself is built and priced correctly.
Fee-for-service practices, which membership revenue functions like from a collections standpoint, often see profit margins above 40%, compared with 25 to 30% for PPO-heavy offices. That gap exists because there’s no adjustment eating into what gets collected, the patient’s monthly or annual fee is the fee. On top of the margin difference, membership plans run well have shown 90%+ patient retention, which speaks directly to the “will this revenue still be here after the sale” question every buyer is quietly asking. A well-documented membership program doesn’t just add a revenue line, it adds a revenue line a buyer can actually trust.
DentalHQ platforms have also seen average annual membership revenue growth of 37% (DentalHQ platform data, 2024), which is the kind of trend a buyer’s team notices when they’re deciding whether a revenue stream is an anomaly or a genuine asset. Real practice results tell the same story across different practice sizes and markets, not just one favorable example.
A modest membership program can add tens of thousands of dollars in recurring annual revenue without requiring the practice to see a single new patient.
If a practice has 2,000 active patients and only 5% enroll in a $35-a-month plan, that’s 100 members, $3,500 a month, and $42,000 a year in revenue that renews on its own, doesn’t depend on a payer, and doesn’t show up as a write-off. Scale that enrollment percentage up, or raise the plan value for patients who want more, and the number moves quickly. None of that math requires a marketing budget or a new patient campaign. It requires asking the patients already in the practice.
Run that same math forward three or four years, with enrollment growing instead of staying flat, and you’re not looking at a side benefit anymore. You’re looking at a second revenue line with its own trend, its own retention rate, and its own story to tell a buyer, separate from whatever insurance is doing that year. That’s the version of this math that actually shows up in a valuation conversation.
The honest answer is well before you plan to sell, because recurring revenue needs a track record to be credible, and a plan launched six months before a transition reads very differently to a buyer than one with two or three years of consistent growth behind it.
Recurring membership revenue improves practice valuation, but only once it has enough history to prove it’s not a one-time bump. A buyer’s diligence team isn’t just looking at what the number is today, they’re looking at the trend line, whether it’s growing, whether renewals are consistent, and whether it would survive a change in ownership. That trend line takes time to build. Build it now, benefit at exit, whether that exit is a sale, a partner buy-in, or simply a practice worth more than it was the year before.
A membership plan adds a recurring, patient-paid revenue line that isn’t subject to insurance write-offs, which is generally viewed as more valuable and more predictable than insurance-dependent revenue of the same size.
As early as possible. Recurring revenue is most credible to a buyer when it has a multi-year track record, so starting years ahead of a planned transition, rather than months, gives the plan time to show a real growth trend.
Insurance revenue is subject to write-offs, averaging around 43% nationally, and depends on payer reimbursement schedules the practice doesn’t control. Membership revenue is patient-paid, renews on a set schedule, and isn’t subject to a payer’s fee schedule at all.
No. Even a modest enrollment rate, around 5% of an active patient base, can generate tens of thousands of dollars in recurring annual revenue, and that percentage typically grows once a plan is actively offered rather than just available.
Not when it’s run on a dedicated platform with clean reporting. A membership program that’s automated and well-documented is easier for a buyer’s team to diligence than one tracked manually, which is where complications, not the plan itself, tend to show up.